Point72 Hong Kong LTD Oric Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.15 - $5.24 $4,164 - $6,927	1,322 Added 1201.82%	1,432 $5,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $11,939 - $31,263	-4,422 Reduced 97.57%	110 $0
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $20,575 - $72,965	4,532 New	4,532 $24,000
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $30,130 - $47,791	-1,895 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $32,916 - $48,019	1,895 New	1,895 $34,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.